![Christopher Boerner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Boerner
Directeur Général chez
BRISTOL-MYERS SQUIBB COMPANY
Fortune : 10 M $ au 31/07/2026
Profil
Christopher S.
Boerner is Chairman & Chief Executive Officer at Bristol Myers Squibb Co. since 2024 and holds the same titles at The Bristol-Myers Squibb Canada Co. He is Director at Capital Health System, Inc. and Pharmaceutical Research & Manufacturers of America.
Starting in 2026, Dr. Boerner will be Independent Director at Colgate-Palmolive Co. Formerly, Dr. Boerner was Marketing Director at Genentech, Inc. in 2010, Independent Director at Achaogen, Inc. from 2014 to 2015, Vice President-Marketing at Dendreon Corp.
in 2010, Executive Vice President-Commercial at Seagen, Inc. from 2014 to 2015, and Associate at McKinsey & Co., Inc. Education includes undergraduate studies at Washington University in St. Louis and graduate and doctorate degrees from Haas School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/03/2026 | 146 890 ( 0,01 % ) | 10 M $ | 31/07/2026 | |
| 11/05/2026 | 1 383 ( 0 % ) | 126 268 $ | 31/07/2026 |
Dernières actualités sur Christopher Boerner
Postes actifs de Christopher Boerner
| Sociétés | Poste | Début |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Directeur Général | 01/11/2023 |
| COLGATE-PALMOLIVE COMPANY | Directeur/Membre du Conseil | 15/03/2026 |
Capital Health System, Inc.
 Capital Health System, Inc. Hospital/Nursing ManagementHealth Services Owns and operates hospitals | Directeur/Membre du Conseil | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Directeur/Membre du Conseil | - |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Specializes in the research, development and manufacturing of oncology, immunology, hematology and cardiovascular diseases | Directeur Général | - |
Anciens postes connus de Christopher Boerner
| Sociétés | Poste | Fin |
|---|---|---|
| ACHAOGEN | Directeur/Membre du Conseil | 10/06/2015 |
| SEAGEN INC. | Corporate Officer/Principal | 30/01/2015 |
| DENDREON CORPORATION | Sales & Marketing | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Sales & Marketing | 01/01/2010 |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Christopher Boerner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Colgate-Palmolive Co.
 Colgate-Palmolive Co. Household/Personal CareConsumer Non-Durables Manufactures and sells oral, personal, home care & pet nutritional products | Consumer Non-Durables |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Capital Health System, Inc.
Capital Health System, Inc. Hospital/Nursing ManagementHealth Services Owns and operates hospitals | Health Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bristol-Myers Squibb Canada Co.
Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Specializes in the research, development and manufacturing of oncology, immunology, hematology and cardiovascular diseases | Health Technology |
